Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Massonnet Castel

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Archives Des Maladies Du Coeur Et Des Vaisseaux|October 1, 1991
[Advantages and limits of programmed autologous transfusion in cardiovascular surgery. Apropos of 524 patients]S Massonnet-Castel, J N Fabiani, V Jebara, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|October 1, 1996
[Pre- and intraoperative management of heparin cross hypersensitivity. Apropos of a case]C Latrémouille, S Massonnet-Castel, J F Baron, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|December 1, 1986
[Low molecular weight heparin in extracorporeal circulation. 1st clinical applications]G Dreyfus, S Massonnet-Castel, E Pélissier, et al.
Haemostasis|January 1, 1986
Partial reversal of low molecular weight heparin (PK 10169) anti-Xa activity by protamine sulfate: in vitro and in vivo study during cardiac surgery with extracorporeal circulationS Massonnet-Castel, E Pelissier, L Bara, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Archives Des Maladies Du Coeur Et Des Vaisseaux|October 1, 1991
[Advantages and limits of programmed autologous transfusion in cardiovascular surgery. Apropos of 524 patients]S Massonnet-Castel, J N Fabiani, V Jebara, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|October 1, 1996
[Pre- and intraoperative management of heparin cross hypersensitivity. Apropos of a case]C Latrémouille, S Massonnet-Castel, J F Baron, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|December 1, 1986
[Low molecular weight heparin in extracorporeal circulation. 1st clinical applications]G Dreyfus, S Massonnet-Castel, E Pélissier, et al.
Haemostasis|January 1, 1986
Partial reversal of low molecular weight heparin (PK 10169) anti-Xa activity by protamine sulfate: in vitro and in vivo study during cardiac surgery with extracorporeal circulationS Massonnet-Castel, E Pelissier, L Bara, et al.
Pageof 2